Citations
31
10.3 per year
Published
2022
Resilient clinical trial infrastructure in the face of COVID-19: a multinational survey
Trials•2022
Authors
JI Forrest, K Thorlund, G Reis, EJ Mills
COVID-19
Abstract
Background: The COVID-19 pandemic significantly impacted clinical trial operations worldwide. We conducted a multinational survey to assess the resilience of clinical trial infrastructure and identify strategies for maintaining research continuity during global health emergencies.
Related Publications
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
The Lancet Global Health • 2022
The Lancet
COVID-19
Effect of early treatment with ivermectin among patients with Covid-19
New England Journal of Medicine • 2022
COVID-19
Ivermectin
A real-time dashboard of clinical trials for COVID-19
The Lancet Digital Health • 2020
The Lancet
COVID-19